Cathepsin A-like activity is possibly the main acidic carboxypeptidase in human platelets

Platelets

Volumn 8, Issue 5, 1997, Pages 355-360

  Ostrowska, Halina ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PROTEINASE; CARBOXYPEPTIDASE B; PROLINE CARBOXYPEPTIDASE; SERINE CARBOXYPEPTIDASE; SERINE PROTEINASE INHIBITOR; THIOL GROUP;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HYDROLYSIS; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0030666145     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109777221     Document Type: Article

References (53)

1. McDonald JK, Barrett AJ. Mammalian Proteases: A Glossary and Bibliography Vol.2: Exopeptidases. New York: Academic Press, 1986.
2. Galljart NJ, Morreau H, Williamsen R, Gillemans N, Bonten EJ, D'Azzo A. Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J Biol Chem 1991; 266: 14754-62.
3. Kawamura Y, Matoba T, Hata T, Doi E. Purification and some properties of cathepsin A of large molecular size from pig kidney. J Biochem 1974; 76: 915-24.
4. Matsuda K. Studies on cathepsins of rat liver lysosomes. III. Hydrolysis of peptides and inactivation of angiotensin and bradykinin by cathepsin A. J Biochem 1976; 80: 659-69.
5. Miller JJ, Changaris DG, Levy RS. Purification, subunit structure and inhibitor profile of cathepsin A. J Chromatogr 1992; 627: 153-62.
6. Pshezhetsky AV, Vinogradova MV, Elsliger MA, El-Zein T, Svedas VK, Potier M. Continuous spectrophotometric assay of human lysosomal cathepsin A/protective protein in normal and galactosialidosis cells. Anal Biochem 1995; 230: 303-7.
7. M1-gangliosidosis and β-galactosialidosis fibroblasts. Biochem J 1992; 285: 833-8.
8. Jackman HL, Tan F, Tamei H, Beurling-Harbury C, Li XY, Skidgel R, Erdös EG. A peptidase in human platelets that deamidates tachykinins. J Biol Chem 1990; 265: 11265-72.
9. Miller JJ, Changaris DG, Levy RS. Conversion of angiotensin I to angiotensin II by cathepsin A isoenzymes of porein kidney. Biochem Biophys Res Commun 1988; 154: 1122-9.
10. Lones M, Chatterjee R, Singh H, Kalmitsky G. Lysosomal carboxypeptidase B from rabbit lung. Purification and characterization. Arch Biochem Biophys 1983; 221: 64-78.
11. Odya CE, Mariknovic D, Hummon KJ, Stewart TA, Erdös EG. Purification and properties of prolylcarboxypeplidase (angiotensinase C) from human kidney. J Biol Chem 1978; 253: 5927-31.
12. Tan F, Morris PW, Skidgel RA, Erdös EG. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C): similarly to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem 1993; 268: 16631-8.
13. Nachman RL, Ferris B. Studies of human platelet protease activity. J clin Invest 1968; 47: 2530-40.
14. Morre S. Amino acid analysis: aqueous dimethyl sulfoxide as solvent for ninhydrin reaction. J Biol Chem 1968; 243: 6281-3.
15. Keil B, Sormova Z. (eds) Laboratorni technika biochemie. Nakl Ceskoslov Acad Ved/Praha 1959: pp. 739-47.
16. Legrand V, Robert B, Szigeti M, Pignaud G, Caen J, Robert L. Etudes sur une protease elastinolytique des plaquettes sanguines humaines. Atherosclerosis 1970; 12: 451-65.
17. Ikeda K, Maruyama K, Suzuki H. Stabilization of porcine spleen cathepsin A with chaotropic ions and its destabilisation with thiols at intralysosomal pH. Int J Biochem 1992; 24: 605-10.
18. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
19. Ostrowska H. Pig platelet acidic carboxypeptidases. Enzyme Protein 1994/1995, 48: 291-7.
20. Iodice AA, Leong V, Weinstock IM. Separation of cathepsin A and D of skeletal muscle. Arch Biochem Biophys 1966; 117: 477-86.
21. Scharpe SL, Vanhoof GC, DeMeester IA, Hendriks DP, Sande ME, Muylle LM, Yaron A. Exopeptidases in human platelets: an indication for proleolytic modulation of biologically active peptides. Clin Chim Acta 1990; 195: 125-32.
22. Ariyoshi H, Kambayashi I, Sakon M. Calpains and calpastatin in human blood platelets. Platelets 1995; 6: 185-9.
23. Psheshetsky AV, Potier M. Direct affinity purification and supermolecular organization of human lysosomal cathepsin A. Arch Biochem Biophys 1994; 313: 64-70.
24. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996; 65: 801-47.
25. Yukawa M, Sakon M, Kambayashi J, Shiba E, Kawasaki T, Ariyoshi H, Mori T. Proteasome and its novel endogenous activator in human platelets. Biochem Biophys Res Commun 1991; 178: 256-62.
26. Figueiredo-Pereira ME, Chen WE, Yuan HM, Wilk S. A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH. Arch Biochem Biophys 1995; 317: 69-78.
27. Holmsen H, Kaplan KL, Dangelmaier CA. Differential requirements for platelet response: a simultaneous study of dense, alpha-granule and acid hydrolase secretion. Biochem J 1982; 208: 9-18.
28. von dem Borne AEG, Decary F. ICSH/IBST working party on platelet serology. Nomenclature of platelet-specific antigens. Vox Sang 1990; 58: 176.
29. Kunicki TJ, Newman PJ. The molecular immunology of human platelet proteins. Blood 1992; 80: 1386-404.
30. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, Mueller-Eckhardt G, Santoso S. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 1: 363-6.
31. 2). J Clin Invest 1993; 92: 2427-32.
32. Kunicki TJ, Nugent DJ, Staats SJ, Orchekowski RP, Wayner EA, Carter WG. The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex. J Biol Chem 1988; 263: 4516-9.
33. Coller BS, Beer JH, Scudder LE, Steinberg MH. Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/ IIIa mediated by adhesive proteins. Blood 1989; 74: 182-92.
34. 1 integrin: a collagen receptor on platelets and other cells. Thromb Haemostas 1995; 74: 813-21.
35. Tan EN, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Shaller JG, Talal N, Winchester RG. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1982; 25: 1271-7.
36. Yanabu M, Nomura S, Fukuroi T, Kawakatsu T, Kido H, Yamaguchi K, Suzuki M, Kokawa T, Yasunaga K. Periodic production of antiplatelet autoantibody directed against GPIIIa in cyclic thrombocytopenia. Acta Haematol 1993; 89: 155-9.
37. Kalb R, Santoso S, Unkelbach K, Kiefel V. Localization of the Br polymorphism on a 144 bp exon of the GP Ia gene and its application in platelet DNA typing. Thromb Haemostas 1994; 71: 651-4.
38. Van Leeuwen EF, van der Yen JTM, Engelfriet CP, von dem Borne AEGK. Specificities of autoantibodies in autoimmune thrombocytopenia. Blood 1982; 59: 23-6.
39. Woods VL, Oh EH, Mason D, McMillan R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984; 63: 368-75.
40. Beardsley D, Speigel J, Jacobs M, Handin R, Lux S. Platelet membrane glycoprotein thrombocytopenias. J clin Invest 1984; 73: 1701-7.
41. McMillan R, Tani P, Millard F, Woods VL. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987; 70: 1040-5.
42. Kekomaki R, Dawson B, McFarland J, Kunicki TJ. Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa. J Clin Invest 1991; 88: 847-54.
43. Fujisawa K, Tani P, O'Toole TE, Ginsberg MH, McMillan R. Different specificities of platelet associated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic immune thrombocytopenic purpura. Blood 1992; 79: 1441-6.
44. Woods VL, Kurata Y, Montgomery RR, Tani P, Mason D, Oh EH, McMillan R. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood 1984; 64: 156-60.
45. Szatkowski NS, Kunicki TJ, Aster RH. Identification of glycoprotein Ib as a target for autoantibody in idiopathic (autoimmune) thrombocytopenic purpura. Blood 1986; 67: 310-5.
46. Devine DV, Curie MS, Rosse WF, Greenberg CS. Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib. Blood 1987; 70: 428-31.
47. Deckmyn H, Chew SL, Vermylen J. Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: a novel cause of acquired qualitative platelet dysfunction. Thromb Haemostas 1990; 64: 74-9.
48. Clancy R, Jenkins E, Firkin B. Qualitative platelet abnormalities in idiopathic thrombocytopenic purpura. N Engl J Med 1972; 286: 622-6.
49. Heyns AP, Fraser J, Retief FP. Platelet aggregation in chronic idiopathic thrombocytopenic purpura. J Clin Pathol 1978; 31: 1239-43.
50. Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69: 1712-20.
51. Yanabu M, Suzuki M, Soga T, Sone N, Nagata H, Nomura S, Kokawa T, Yasunaga K. Influences of antiplatelet autoantibodies on platelet function in immune thrombocytopenic purpura. Eur J Haematol 1991; 46: 101-6.
52. b are expressed on the very late activation antigen 2 (VLA-2) of T lymphocytes. Hum Immunol 1989; 25: 237-46.
53. 1, activity on human platelets. Blood 1993; 82: 2693-703.